D. Leong

Monodispersed DOTA-PEG–Conjugated Anti-TAG-72 Diabody Has Low Kidney Uptake and High Tumor-to-Blood Ratios Resulting in Improved 64Cu PET

J. Bading, P. Hudson, J. Shively, 2010, Journal of Nuclear Medicine.

A novel soluble complement receptor 1 fragment with enhanced therapeutic potential

Michael J. Wilson, A. Zuercher, Adriana Baz Morelli, 2020, The Journal of biological chemistry.

Therapeutic Targeting of the G-CSF Receptor Reduces Neutrophil Trafficking and Joint Inflammation in Antibody-Mediated Inflammatory Arthritis

Michael J. Wilson, M. Ng, Adriana Baz Morelli, 2016, The Journal of Immunology.

Vaccines that facilitate antigen entry into dendritic cells

M. Plebanski, S. Xiang, P. Mottram, 2004, Immunology and cell biology.

Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.

David Leong, Magdalena Plebanski, S. Gloster, 2007, Molecular pharmaceutics.

A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis.

M. Davis, C. Goodnow, W. Ho, 1997, Immunity.

Site-specific conjugation of monodispersed DOTA-PEGn to a thiolated diabody reveals the effect of increasing peg size on kidney clearance and tumor uptake with improved 64-copper PET imaging.

J. Bading, D. Wheatcroft, P. Hudson, 2011, Bioconjugate chemistry.

rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and FcγRs

A. Zuercher, S. Koernig, Adriana Baz Morelli, 2018, The Journal of Immunology.

Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivo.

Adriana Baz Morelli, S. Dower, M. Hardy, 2022, The Biochemical journal.